期刊文献+

高浓度抗生素溶液对椎间盘细胞影响的研究

Influences of the high concentrations of cefazolin and clindamycin on the viability and proliferation of nucleus pulposus cell
原文传递
导出
摘要 [目的]检测高浓度的头孢唑林钠及克林霉素对兔腰椎间盘髓核细胞活力及增殖能力的影响。[方法]通过在体外分离、培养新西兰兔髓核细胞,体外扩增培养至第1代,采用CCK-8及RT-PCR等方法,检测4个浓度(0mg/ml、0.25mg/ml、0.5mg/ml、1mg/ml)的头孢唑啉钠及克林霉素对于兔腰椎间盘髓核细胞活力及增殖能力的影响。[结果]当头孢唑啉钠浓度超过0.5mg/ml、克林霉素浓度超过0.25mg/ml时,髓核细胞Ⅱ型胶原及蛋白多糖的表达下降,浓度在1.0mg/ml时达到最低。头孢唑啉钠浓度超过0.5mg/ml、克林霉素浓度超过0.25mg/ml时,明显影响细胞活力,小于以上浓度时细胞活性无明显影响。[结论]高浓度的头孢唑林钠及克林霉素抗生素对于体外培养的兔髓核细胞的活力、增殖能力具有抑制作用。 [ Objective] To observe the influences of the high concentrations of cefazolin and clindamycin on the viability and proliferation of nucleus pulposus cell. [ Method] NP cells from rabbit disc were harvested and cultured in vitro. Then they were randomly divided into eight groups with different concentrations of cefazolin and clindamycin(0 mg/ml,0.25 mg/ml,0.5 mg/ml, 1mg/ml). Semi-quantitative real-time polymerase chain reaction (RT-PCR) was used to quantify type Ⅱ collagen and aggrecan respectively. The changes of cells viability were detected by CCK - 8 staining. [ Result] Cefazolin and clindamyein can inhibit type Ⅱ collagen and aggrecan expression at the concentration of exceeding 0.5 mg/ml and 0.25 mg/ml and reached their peaks at 1.0 mg/ml. Cefazolin and clindamycin affected the viability of the NP cells exposed at the concentration of exceeding 0.5 mg/ ml and 0.25 mg/ml. The concentration below the above level didn't obviously affect cell activity. [ Conclusionj Cefazolin and clindamycin can inhibit type Ⅱ collagen and aggrecan expression at the concentration of exceeding 0.5 mg/ml and 0.25 mg/ml. Cefazolin and clindamycin affect the viability of the NP cells exposed at the concentration of exceeding 0.5 mg/ml and 0.25mg/ ml.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2013年第1期91-95,共5页 Orthopedic Journal of China
关键词 髓核细胞 头孢唑啉钠 克林霉素 nucleus pulposus cell, cefazolin, clindamycin
  • 相关文献

参考文献17

  • 1Ahn Y,Lee SH. Postoperative spondylodiscitis following transforamihal percutaneous endoscopic lumbar disccctomy:clinical characteristics and preventive strategies[J].British Journal of Neurosurgery,2012.482-486.
  • 2Gerometta A,Bittan F,Rodriguez-Olaverri JC. Postoperative spondilodiscitis[J].International Orthopaedics,2012.433-438.
  • 3梁伦高,靳安民,于博,朱立新,周初松,吴继功,周赤龙.术后椎间盘炎不同治疗方法的疗效分析(附53例报告)[J].中国矫形外科杂志,2004,12(5):335-337. 被引量:10
  • 4刘玉军,李学民,朱瑜琪.闭式抗生素灌洗治疗腰椎间盘术后椎间隙感染的效果[J].中国矫形外科杂志,2007,15(7):554-556. 被引量:14
  • 5Hoelscher GL,Gruber HE,Coldham G. Effects of very high antibiotic concentrations on human intervertebral disc cell proliferation,viability,and metabolism in vitro[J].Spine (Phila Pa 1976),2000.1871-1877.
  • 6张文捷,张亮,赵春明,张宁.旋转式生物反应器内构建组织工程髓核[J].中华医学杂志,2010,90(31):2215-2218. 被引量:6
  • 7Herget GW,Adler CP. The intervertebral disk in anatomy and pathology[J].Versicherungsmedizin,2000.179-184.
  • 8Chan WC,Sze KL,Samartzis D. Structure and biology of the intervertebral disk in health and disease[J].Orthopedic Clinics of North America,2011.447-464.
  • 9Lindholm TS,Pylkkanen P. Discitis following removal of intervertebral disc[J].Spine (Phila Pa 1976),1982.618-622.
  • 10张旭,张春和,高金伟,傅磊武.腰椎间盘术后椎间隙感染的早期诊断治疗[J].中国矫形外科杂志,2005,13(3):232-233. 被引量:19

二级参考文献26

  • 1董彦,刘英杰,刘尚礼,杨伟光,黄永杰,余江.原发性化脓性椎间隙感染发病机理及治疗方法的探讨[J].中国矫形外科杂志,2004,12(13):983-984. 被引量:23
  • 2栗向明,陈允震,任井斌,刘海春.胸腰椎后路内固定术后感染的临床分析[J].中国矫形外科杂志,2004,12(14):1108-1109. 被引量:11
  • 3张旭,张春和,高金伟,傅磊武.腰椎间盘术后椎间隙感染的早期诊断治疗[J].中国矫形外科杂志,2005,13(3):232-233. 被引量:19
  • 4Gallucci M,Limbucci N,Paonessa A,et al.Degenerative disease of the spine.Neuroimaging Clin N Am,2007,17:87-103.
  • 5Glaser J,Stanley M,Sayre H,et al.A 10-year follow-up evaluation of l umbar spine fusion with pedicle screw fixation.Spine,2003,28:1390-1395.
  • 6Richardson SM,Mobasheri A,Freemont AJ,et al.Intervertebral disc biology,degeneration and novel tissue engineering and regenerative medicine therapies.Histol Histopathol,2007,22:1033-1041.
  • 7Hsieh AH,Twomey JD.Cellular mechanobiology of the intervertebral disc:new directions and approach.J Biomech,2009,68:887-891.
  • 8Mizuno H,Roy AK,Zaporojan V,et al.Biomechanical and biochemical characterization of composite tissue-engineered intervertebral discs.Bioma Terials,2006,27:362-370.
  • 9Abousleiman RI,Sikavitsas VI.Bioreactors for tissues of the musculoskeletal system.Adv Exp Med Biol,2006,585:243-259.
  • 10Cherry RS,Eleftherios TP.Physical mechanisms of cell damage in microcarrier cell culture bioreactors.Biotech and Bioeng,1988,32:1001-1014.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部